The use of distamycin A in human lymphocyte cultures

Hum Genet. 1984;65(4):377-84. doi: 10.1007/BF00291563.

Abstract

The effect of the oligopeptide antibiotic distamycin A on human lymphocyte cultures was examined. Distamycin A specifically inhibits the condensation of the Y heterochromatin and induces a fragile site in the chromosome 16 (band q22) in some individuals. The optimal culture conditions under which an undercondensation of the Y heterochromatin and an induction of the fragile site in 16q22 can be achieved by in vitro treatment of lymphocytes were determined. This also permits the use of distamycin A in routine diagnostics of human chromosomes. The use of this technique in the analysis of translocations involving the Y chromosome is presented. The distamycin A-DNA interaction and the different possible explanations for the distamycin A-induced undercondensations of the Y heterochromatin and fragile sites 16q22 are discussed.

MeSH terms

  • Cells, Cultured
  • Chemical Phenomena
  • Chemistry
  • Chromosome Banding
  • Chromosome Fragile Sites
  • Chromosome Fragility
  • Chromosomes, Human, 16-18 / ultrastructure*
  • DNA / metabolism
  • Distamycins / pharmacology*
  • Dose-Response Relationship, Drug
  • Female
  • Heterochromatin / drug effects
  • Heterochromatin / ultrastructure*
  • Humans
  • Karyotyping
  • Lymphocytes / ultrastructure*
  • Male
  • Pyrroles / pharmacology*
  • Y Chromosome / ultrastructure*

Substances

  • Distamycins
  • Heterochromatin
  • Pyrroles
  • stallimycin
  • DNA